Irving S Johnson - Net Worth and Insider Trading

Irving S Johnson Net Worth

The estimated net worth of Irving S Johnson is at least $461,468 dollars as of 2024-11-13. Irving S Johnson is the Director of Ligand Pharmaceuticals Inc and owns about 3,822 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $461,468. Details can be seen in Irving S Johnson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Irving S Johnson has not made any transactions after 2003-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Irving S Johnson

To

Irving S Johnson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Irving S Johnson owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .

Click here to see the complete history of Irving S Johnson’s form 4 insider trades.

Insider Ownership Summary of Irving S Johnson

Ticker Comapny Transaction Date Type of Owner
LGND Ligand Pharmaceuticals Inc 2006-06-14 director

Irving S Johnson Latest Holdings Summary

Irving S Johnson currently owns a total of 1 stock. Irving S Johnson owns 3,822 shares of Ligand Pharmaceuticals Inc (LGND) as of December 1, 2003, with a value of $461,468.

Latest Holdings of Irving S Johnson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LGND Ligand Pharmaceuticals Inc 2003-12-01 3,822 120.74 461,468

Holding Weightings of Irving S Johnson


Irving S Johnson Form 4 Trading Tracker

According to the SEC Form 4 filings, Irving S Johnson has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 1,353 shares on December 1, 2003, which brought Irving S Johnson around $112,692.

Insider Trading History of Irving S Johnson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Irving S Johnson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Irving S Johnson Ownership Network

Ownership Network List of Irving S Johnson

No Data

Ownership Network Relation of Irving S Johnson

Insider Network Chart

Irving S Johnson Owned Company Details

What does Ligand Pharmaceuticals Inc do?

Who are the key executives at Ligand Pharmaceuticals Inc?

Irving S Johnson is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .

Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary

Over the past 18 months, Irving S Johnson made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .

In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 106,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,727 shares.

Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ligand Pharmaceuticals Inc Insider Transactions

No Available Data

Irving S Johnson Mailing Address

Above is the net worth, insider trading, and ownership report for Irving S Johnson. You might contact Irving S Johnson via mailing address: C/o Ligand Pharmaceuticals Inc.,, 10275 Science Center Dr., San Diego Ca 92121.